Significant support from investors including the European Investment Fund Fund to invest in first and best-in-class European life science companies in drug development and digital health STRASSEN, Luxembourg, June 29, 2023 /PRNewswire/ — Vesalius Biocapital, the specialist life sciences…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.